Radix Biosolutions LLC

Georgetown, TX

UEI
WKYYAE2UVK79
CAGE
3VJG0
Primary NAICS
325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
111 Cooperative Way #120, Georgetown, TX 78626, USA
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
89 Services, Not Elsewhere Classified
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $215,940
FY2025 $97,230
FY2024 $419,580
FY2023 $149,850

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Agriculture $215,940

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Radix Biosolutions LLC, a for-profit limited liability company and manufacturer of goods based in Georgetown, Texas, supplies food allergen detection assay kits and bioanalytical diagnostic reagents to federal food safety and public health agencies exclusively as a prime contractor, competing on full-and-open basis with no small business set-aside participation beyond one Total Small Business-set-aside purchase order.

Radix's capability portfolio centers on XMAP Food Allergen Detection Assay Kits—multiplexed suspension array diagnostic tools that enable federal laboratories to detect and quantify allergens in food samples in support of labeling compliance and enforcement. Representative work includes a $215,940 firm fixed-price purchase order from USDA's Food Safety and Inspection Service (FSIS) for allergen test kits awarded March 9, 2026 and scheduled for completion May 8, 2026; a $174,825 small-business-set-aside purchase order from the Food and Drug Administration for XMAP reagents awarded July 9, 2024 with completion through December 31, 2025; and a $149,850 FDA purchase order for XMAP allergen detection assay kits awarded August 31, 2023. Radix also holds a single-award indefinite delivery contract with FSIS valued at $250,000 (awarded November 15, 2023, expiring November 14, 2024), from which two delivery orders totaling $244,755 have been placed.

Customer concentration is heavily weighted toward the Department of Health and Human Services. The CDC's Office of Acquisition Services leads by count (33 awards, $14 million combined potential value, 59% of total dollars) and by dollar value; the FDA ranks second at 23 awards and $2.6 million; and FSIS accounts for 7 awards and $853 thousand. The Department of Homeland Security Science and Technology Directorate holds 3 awards and $4.1 million (18% of potential value), representing Radix's only meaningful federal customer outside HHS and USDA. Together, these five agencies account for 94% of combined potential value across 86% of all awards.

Radix's award footprint reflects long-term customer relationships with modest recent activity velocity. The source documents eighty total prime awards dating back to 2004, with one award in 2022, two in 2023, three in 2024, one in 2025, and one in 2026 — a pace of approximately one award annually in recent years. Combined potential value across all eighty awards is $23.7 million, with $13.1 million obligated (55% of potential). Task order work flows through three named IDCs: CDC-issue HHSF223200910001I (4 task orders, $321 thousand), HHSD200200721946I (3 task orders, $3.3 million), and USDA FSIS 123A9424D0001 (2 task orders, $245 thousand).

The vendor maintains no subcontract footprint; all eighty awards are prime contracts. Primary NAICS concentration runs to 325999 (All Other Miscellaneous Chemical Product and Preparation Manufacturing, 42 awards) and 325413 (In-Vitro Diagnostic Substance Manufacturing, 9 awards), with supporting NAICS in biotech research and development and analytical instrument manufacturing. PSC codes align: Laboratory Equipment and Supplies accounts for 55 awards, with In Vitro Diagnostic Substances and Medical/Surgical Instruments rounding out the classification profile.

SBA capabilities narrative

Radix BioSolutions develops and manufactures microsphere based products for customers in the research community, the drug discovery industry, biowarfare detection industry and the agricultural industry.

Quick answers

Is Radix Biosolutions LLC registered in SAM.gov?

Yes. Radix Biosolutions LLC's SAM.gov registration is active through April 21, 2027.

What is Radix Biosolutions LLC's CAGE code?

Radix Biosolutions LLC's CAGE code is 3VJG0, and its Unique Entity ID (UEI) is WKYYAE2UVK79.

How much has Radix Biosolutions LLC received in federal contracts?

Federal contracts obligated $97,230 to Radix Biosolutions LLC in fiscal year 2025 and $882,600 in fiscal years 2023 through 2027.

What is Radix Biosolutions LLC's most recent federal award?

Radix Biosolutions LLC's most recent federal contract award is Xmap food allergen detection assay allergen test kits for the eastern laboratory (123A9426P0006), from Office of Administrative Services Procurement Management Branch (FSIS), on March 9, 2026.

On GovTribe

See Radix Biosolutions LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe